PTC Therapeutics
PTCT
PTCT
181 hedge funds and large institutions have $2.78B invested in PTC Therapeutics in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 69 increasing their positions, 53 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more funds holding
Funds holding: 180 → 181 (+1)
0.39% more ownership
Funds ownership: 105.24% → 105.63% (+0.39%)
11% less capital invested
Capital invested by funds: $3.13B → $2.78B (-$356M)
Holders
181
Holding in Top 10
6
Calls
$4.88M
Puts
$4.6M
Top Buyers
| 1 | +$27.9M | |
| 2 | +$18.8M | |
| 3 | +$14.3M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$11.8M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.1M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$13.1M | |
| 3 | -$5.38M | |
| 4 |
Morgan Stanley
New York
|
-$5.12M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.08M |